Please provide your email address to receive an email when new articles are posted on . For children diagnosed with allergies to food, insect venom, drugs, or other allergenic substances, epinephrine ...

Overdose and anaphylaxis are two serious medical emergencies that require immediate intervention and can be fatal if not treated in time. Supplying every AED first-aid box with epinephrine ...

REPORTER: SEVEN-YEAR-OLD AIDEN SEGOOL LOOKS JUST LIKE ANY OTHER KID ABOUT TO START SCHOOL. BUT WHAT YOU CAN’T SEE IS THAT AIDEN HAS A LIFE-THREATENING ALLERGY TO DAIRY AND EGGS. >> EVERYONE GETS TO ...

Lineage's epinephrine auto-injector is the only generically priced epinephrine auto-injector currently available. This authorized generic epinephrine injection, USP auto-injector, is being ...

Epinephrine Injection (Auto-Injector) is a prescription medicine in a disposable, prefilled automatic injection device (auto-injector) used to treat life-threatening, allergic emergencies including ...

People with severe allergies now have more choices for which epinephrine auto-injector to carry in case they suffer a life-threatening attack, and most pay less for it than they did when the EpiPen ...

As part of the back-to-school rush, GoodRx, a platform for medication savings, reports the demand for epinephrine (EpiPen, EpiPen Jr, Adrenaclick, Auvi-Q) auto-injectors tends to spike in the summer ...

The company has indicated that if the new auto-injector is approved they expect it to be available for patients in the first half of 2018. The Food and Drug Administration (FDA) has granted Priority ...

The Food and Drug Administration approved a new version of kaléo’s epinephrine auto-injector, Auvi-Q, specifically designed for children. Here are three things to know. The Auvi-Q 0.1 milligram ...

Walgreens becomes first retail pharmacy to offer access to AUVI-Q auto-injectors at no cost for commercially insured patients who are eligible for kaléo’s patient support programs. For patients who ...

Potential milestone payments could bring Intelliject’s take to $230 million. Sanofi-aventis obtained the rights to Intelliject’s epinephrine auto-injector for the emergency treatment of anaphylaxis in ...